Search Results - "Oba, Hanako"

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer by HAYASHI, YUJI, TAKEI, HIROYUKI, NOZU, SATOSHI, TOCHIGI, YOSHIHIRO, ICHIKAWA, AKIHIRO, KOBAYASHI, NAOKI, KUROSUMI, MASAFUMI, INOUE, KENICHI, YOSHIDA, TAKASHI, NAGAI, SHIGENORI E, OBA, HANAKO, TABEI, TOSHIO, HORIGUCHI, JUN, TAKEYOSHI, IZUMI

“…In the present study, clinical tumor response following neoadjuvant chemotherapy (NAC) was diagnosed by magnetic resonance imaging (MRI) and…”
Get full text

ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes by Suda, Tetsuji, Oba, Hanako, Takei, Hiroyuki, Kurosumi, Masafumi, Hayashi, Shin-ichi, Yamaguchi, Yuri

“…► Carcinoma-associated fibroblasts (CAFs) are able to activate estrogen receptor (ER) in breast cancer. ► CAF-specific ER-activating ability varied among…”
Get full text

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages? by Takei, Hiroyuki, Kurosumi, Masafumi, Yoshida, Takashi, Hayashi, Yuji, Higuchi, Toru, Uchida, Sayaka, Ninomiya, Jun, Oba, Hanako, Inoue, Kenichi, Nagai, Shigenori, Tabei, Toshio

“…Aromatase inhibitors (AIs) were more effective than tamoxifen as a neoadjuvant endocrine therapy (NAE) for postmenopausal women with estrogen receptor…”
Get full text

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation by Takei, Hiroyuki, Yoshida, Takashi, Kurosumi, Masafumi, Inoue, Kenichi, Matsumoto, Hiroshi, Hayashi, Yuji, Higuchi, Toru, Uchida, Sayaka, Ninomiya, Jun, Kubo, Kazuyuki, Oba, Hanako, Nagai, Shigenori, Tabei, Toshio

“…Background It is still controversial whether axillary lymph node (ALN) dissection (ALND) can be omitted after negative sentinel lymph node (SLN) biopsy (SLNB)…”
Get full text

Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies by Takei, Hiroyuki, Kurosumi, Masafumi, Yoshida, Takashi, Ishikawa, Yuko, Hayashi, Yuji, Ninomiya, Jun, Tozuka, Katsunori, Oba, Hanako, Inoue, Kenichi, Nagai, Shigenori, Saito, Yoshihiro, Kazumoto, Tomoko, Saitoh, Jun-ichi, Tabei, Toshio

“…Background It is currently unclear which patients with breast cancer with sentinel lymph node (SLN) metastases do not need axillary lymph node dissection…”
Get full text

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance by Gohno, Tatsuyuki, Seino, Yuko, Hanamura, Toru, Niwa, Toshifumi, Matsumoto, Mitsuyo, Yaegashi, Nobuo, Oba, Hanako, Kurosumi, Masafumi, Takei, Hiroyuki, Yamaguchi, Yuri, Hayashi, Shin‐ichi

“…To predict the efficacy of hormonal therapy at the individual‐level, immunohistochemical methods are used to analyze expression of classical molecular…”
Get full text

Laparoscopic Total Gastrectomy(LTG)in Patient with Multiple Gastric Neuroendocrine Tumor Related to Multiple Endocrine Neoplasia Type 1 - Two Case Reports by Mori, Yoshihiro, Yamada, Tatsuya, Ehara, Kazuhisa, Arai, Shu, Kageyama, Yumiko, Kawashima, Yoshiyuki, Nomura, Satoshi, Kamio, Yukinori, Oka, Daiji, Fukuda, Takashi, Sakamoto, Hirohiko, Oba, Hanako, Kurosumi, Masafumi, Akagi, Kiwamu

“…We herein report 2 cases of laparoscopic total gastrectomy(LTG)in patient with multiple gastric neuroendocrine tumor (NET)related to multiple endocrine…”
Get more information

A case of intraductal mucinous neoplasms with the whole main pancreatic duct dilation treated via segment pancreatectomy by Yamaura, Tadayoshi, Sakamoto, Hirohiko, Amikura, Katsumi, Tanaka, Yoichi, Oba, Hanako, Kurosumi, Masafumi

“…The patient was a 77-year-old woman. She was diagnosed as intraducal papillary mucinous neoplasms (IPMN). She refused an operation for 3 years. After all, a…”
Get more information

Values of tumor-infiltrating lymphocytes (TILs), CD8+ TILs, and PDL-1 for predicting pathological complete response and prognosis in HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab by Kurozumi, Sasagu, Inoue, Kenichi, Kurosumi, Masafumi, Matsumoto, Hiroshi, Hayashi, Yuji, Tozuka, Katsunori, Kubo, Kazuyuki, Komatsu, Kei, Takai, Ken, Nagai, Shigenori E., Oba, Hanako, Horiguchi, Jun

“…Abstract only…”
Get full text

Impact of combining PgR score and original preoperative endocrine prognostic index (PEPI) score as a prognostic factor of neoadjuvant endocrine therapy using exemestane in postmenopausal ER-positive/HER2-negative breast cancer by Kurozumi, Sasagu, Matsumoto, Hiroshi, Tozuka, Katsunori, Hayashi, Yuji, Inoue, Kenichi, Nagai, Shigenori E., Oba, Hanako, Horiguchi, Jun, Takeyoshi, Izumi, Kurosumi, Masafumi

“…Abstract only…”
Get full text

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia with a Central and Peripheral Carcinoid and Multiple Tumorlets: A Case Report Emphasizing the Role of Neuropeptide Hormones and Human Gonadotropin-Alpha by Oba, Hanako, Nishida, Kazunori, Takeuchi, Shingo, Akiyama, Hirohiko, Muramatsu, Koji, Kurosumi, Masafumi, Kameya, Toru

“…We report a case of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). We performed immunohistochemical analysis of 17 neuropeptides and…”
Get full text

Abstract P2-04-10: Utility of simultaneous HER2 protein and gene assessment for the evaluation of discrepancy and intratumoral heterogeneity of HER2 status and the prediction of prognosis in invasive breast cancer using the gene-protein assay (GPA) by Kurozumi, Sasagu, Padilla, Mary, Kurosumi, Masafumi, Matsumoto, Hiroshi, Hayashi, Yuji, Tozuka, Katsunori, Nagai, Shigenori E, Inoue, Kenichi, Oba, Hanako, Horiguchi, Jun, Takeyoshi, Izumi, Ranger-Moore, Jim, Dennis, Eslie, Nitta, Hiroaki

“…Background: The eligibility of patients for HER2-targeted therapies is determined by the evaluation of HER2 gene amplification and HER2 protein overexpression…”
Get full text

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer by SAKUMA, KAORI, KUROSUMI, MASAFUMI, OBA, HANAKO, KOBAYASHI, YASUHITO, TAKEI, HIROYUKI, INOUE, KENICHI, TABEI, TOSHIO, OYAMA, TETSUNARI

“…Although triple-negative breast cancer (TNBC) is associated with a poor prognosis, recent reports have indicated that a higher proportion of TNBC patients…”
Get full text

Estrogen receptor (ER), Ki-67, p27 Kip1 , and histologic grade as predictors of pathologic complete response (pCR) in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy (NAC) using fluorouracil, epirubicin, and cyclophosphamide (FEC), taxanes, and trastuzumab by Kurozumi, Sasagu, Inoue, Kenichi, Takei, Hiroyuki, Matsumoto, Hiroshi, Yoshida, Takashi, Hayashi, Yuji, Ninomiya, Jun, Kubo, Kazuyuki, Nagai, Shigenori E, Oba, Hanako, Kurosumi, Masafumi, Tabei, Toshio, Horiguchi, Jun, Takeyoshi, Izumi

“…Abstract only 613 Background: NAC with taxanes and FEC concurrently with trastuzumab is a potent regimen in patients with HER2-positive breast cancer (BC)…”
Get full text

True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment by Yoshida, Takashi, Takei, Hiroyuki, Kurosumi, Masafumi, Ninomiya, Jun, Ishikawa, Yuko, Hayashi, Yuji, Tozuka, Katsunori, Oba, Hanako, Kawanowa, Kaori, Inoue, Kenichi, Tabei, Toshio

“…Ipsilateral breast tumor relapse (IBTR) after breast-conserving treatment (BCT) may represent two distinct types of lesion, including a true recurrence (TR) or…”
Get more information

Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis by OMOTO, YAWARA, KUROSUMI, MASAFUMI, HOZUMI, YASUO, OBA, HANAKO, KAWANOWA, KAORI, TAKEI, HIROYUKI, YASUDA, YOSHIKAZU

“…In this study, we conducted an immunohistochemical analysis of primary breast tumors and metachronous brain metastases to compare the differences in the…”
Get full text

Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer by Yoshida, Takashi, Takei, Hiroyuki, Kurosumi, Masafumi, Ninomiya, Jun, Ishikawa, Yuko, Hayashi, Yuji, Tozuka, Katsunori, Oba, Hanako, Inoue, Kenichi, Tabei, Toshio

“…Abstract Ipsilateral breast tumor relapse (IBTR) is a potentially a significant problem after breast conserving surgery (BCS). With a median follow-up period…”
Get full text

Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer by Takei, Hiroyuki, Kurosumi, Masafumi, Yoshida, Takashi, Ninomiya, Jun, Ishikawa, Yuko, Hayashi, Yuji, Tozuka, Katsunori, Asakawa, Hideki, Oba, Hanako, Inoue, Kenichi, Tabei, Toshio

“…Abstract It remains to be clarified whether a positive sentinel lymph node biopsy (SLNB) can predict the number of metastatic axillary nodes. This study…”
Get full text

Mammaplasty using an inverted-T technique following the excision of a giant phyllodes tumor by Kubo, Kazuyuki, Hayashi, Yuji, Takei, Hiroyuki, Yoshida, Takashi, Matsumoto, Hiroshi, Kurozumi, Sasagu, Kurosumi, Masafumi, Oba, Hanako, Saito, Takashi, Hamahata, Atsumori, Sakurai, Hiroyuki

“…We report the case of a woman with a giant phyllodes tumor who successfully underwent a mammaplasty after breast-conserving surgery (BCS). The patient was a…”
Get full text